Published in Anal Biochem on February 01, 1990
Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. Am J Hum Genet (2009) 2.09
Repair of 3-methylthymine and 1-methylguanine lesions by bacterial and human AlkB proteins. Nucleic Acids Res (2004) 1.75
Prevalence of loss-of-function FTO mutations in lean and obese individuals. Diabetes (2009) 1.54
Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor. Kidney Int (2017) 1.38
Viral AlkB proteins repair RNA damage by oxidative demethylation. Nucleic Acids Res (2008) 1.19
Purification and initial characterization of proline 4-hydroxylase from Streptomyces griseoviridus P8648: a 2-oxoacid, ferrous-dependent dioxygenase involved in etamycin biosynthesis. Biochem J (1996) 1.09
Inhibition of prolyl 4-hydroxylase by oxalyl amino acid derivatives in vitro, in isolated microsomes and in embryonic chicken tissues. Biochem J (1994) 1.01
Direct and continuous assay for prolyl 4-hydroxylase. Anal Biochem (2008) 0.89
Schizosaccharomyces pombe Ofd2 is a nuclear 2-oxoglutarate and iron dependent dioxygenase interacting with histones. PLoS One (2011) 0.80
A stereochemical concept for the catalytic mechanism of prolylhydroxylase: applicability to classification and design of inhibitors. J Theor Biol (1982) 1.91
Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase. J Biol Chem (1986) 1.75
The 2-oxoglutarate binding site of prolyl 4-hydroxylase. Identification of distinct subsites and evidence for 2-oxoglutarate decarboxylation in a ligand reaction at the enzyme-bound ferrous ion. Eur J Biochem (1984) 1.56
Ascorbate is consumed stoichiometrically in the uncoupled reactions catalyzed by prolyl 4-hydroxylase and lysyl hydroxylase. J Biol Chem (1984) 1.50
Differences between collagen hydroxylases and 2-oxoglutarate dehydrogenase in their inhibition by structural analogues of 2-oxoglutarate. Biochem J (1985) 1.13
Schistosoma mansoni-related morbidity on Ukerewe Island, Tanzania: clinical, ultrasonographical and biochemical parameters. Trop Med Int Health (1997) 1.12
Inhibition of prolyl hydroxylation and procollagen processing in chick-embryo calvaria by a derivative of pyridine-2,4-dicarboxylate. Characterization of the diethyl ester as a proinhibitor. Biochem J (1991) 1.03
Time-dependent inactivation of chick-embryo prolyl 4-hydroxylase by coumalic acid. Evidence for a syncatalytic mechanism. Biochem J (1987) 1.01
Inhibition of prolyl 4-hydroxylase by oxalyl amino acid derivatives in vitro, in isolated microsomes and in embryonic chicken tissues. Biochem J (1994) 1.01
Characterization of a low-relative-molecular-mass prolyl 4-hydroxylase from the green alga Chlamydomonas reinhardii. Biochem J (1987) 0.98
Selective inhibition of hepatic collagen accumulation in experimental liver fibrosis in rats by a new prolyl 4-hydroxylase inhibitor. Hepatology (1998) 0.94
Prolyl 4-hydroxylase from Volvox carteri. A low-Mr enzyme antigenically related to the alpha subunit of the vertebrate enzyme. Biochem J (1988) 0.88
Structural requirements for the utilization of ascorbate analogues in the prolyl 4-hydroxylase reaction. Biochem J (1994) 0.85
Beneficial effects of inhibitors of prolyl 4-hydroxylase in CCl4-induced fibrosis of the liver in rats. J Hepatol (1991) 0.83
Fibrosis of the liver in rats induced by bile duct ligation. Effects of inhibition by prolyl 4-hydroxylase. J Hepatol (1991) 0.83
Pyrroloquinoline quinone and molecules mimicking its functional domains. Modulators of connective tissue formation? FEBS Lett (1987) 0.82
Suppression of immunopathology in schistosomiasis by interleukin-2-targeted fusion toxin, DAB389IL-2. I. Studies of in vitro and in vivo efficacy. Cell Immunol (1995) 0.79
Specific inactivation of prolyl 4-hydroxylase and inhibition of collagen synthesis by oxaproline-containing peptides in cultured human skin fibroblasts. J Biol Chem (1990) 0.79
Prolyl hydroxylase activity in tissue homogenates of annelids from deep sea hydrothermal vents. Matrix Biol (1998) 0.78
Transglutaminase and polyamine dependence of effector functions of human immunocompetent cells. The effect of specific inhibitors on lymphocyte proliferation and granulocyte chemiluminescence. FEBS Lett (1982) 0.77
The bradykinin B2 receptor antagonist Icatibant (HOE 140) corrects avid Na+ retention in rats with CCl4-induced liver cirrhosis: possible role of enhanced microvascular leakage. Eur J Pharmacol (1997) 0.77
Immunological effects of thalidomide. Inactivity of the drug and several of its hydrolysis products in mononucleocyte proliferation tests. Arzneimittelforschung (1986) 0.77
Serum laminin P1 levels do not reflect critically elevated portal pressure in patients with liver cirrhosis. Hepatogastroenterology (1997) 0.76
Interference in clinical laboratory tests, with special regard to the bilirubin assay: effects of a metabolite of the new prolyl 4-hydroxylase inhibitor, Lufironil. Eur J Clin Chem Clin Biochem (1994) 0.75
Inhibition of human prolyl hydroxylase as common biochemical denominator of the non-sedative effects of thalidomide in man. Z Naturforsch C (1977) 0.75
Thalidomide--a therapy for the immunological consequences of HIV infection? Med Hypotheses (1989) 0.75
Effects of hydrazyl group containing drugs on leucocyte functions: an immunoregulatory model for the hydralazine-induced lupus-like syndrome. J Immunopharmacol (1985) 0.75
[Experimental studies of the inhibition of fibrogenesis]. Z Gastroenterol (1992) 0.75
Butyrate-synchronized cloned T cells retain their dependence on interleukin-2 for growth induction. A model system for growth regulation. Exp Cell Res (1987) 0.75